Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (250)
- Medicine safety (167)
- Prescription medicines (150)
- COVID-19 (144)
- Regulatory compliance (130)
- COVID-19 vaccines (88)
- Legislation (83)
- Therapeutic goods regulation (75)
- Listed medicines (57)
- Non-prescription medicines (53)
- Safety (51)
- Medical devices safety (45)
- Complementary medicines (39)
- Vaping hub (39)
- Manufacturing (36)
- Over the counter (OTC) medicines (32)
- Labelling and packaging (30)
- Assessed listed medicines (26)
- Australian Register of Therapeutic Goods (ARTG) (26)
- Scheduling (national classification system) (24)
- Compliance and enforcement hub (23)
- Alert/Advisory (22)
- Medicinal cannabis hub (21)
- Import and export (19)
- Shortages (13)
- In Vitro Diagnostic medical devices (IVDs) (11)
- Weight loss products (11)
- Sunscreens (10)
- Advisory bodies and committees (5)
- Biological medicines (4)
- Cosmetics (4)
- Registered complementary medicines (4)
- Blood and blood components (3)
- Clinical trials (3)
- Fees and payments (2)
- Prescription opioids hub (2)
- Unique Device Identification (UDI) hub (2)
- Advanced therapies (1)
- Blood safety (1)
- Breast implant hub (1)
- Travelling with health products (1)
Search
1110 result(s) found, displaying 1 to 25
-
NewsWe are aware of a CHOICE report where a number of sunscreens were found to not meet their claimed Sun Protection Factor (SPF) ratings.
-
Media releasesThe Therapeutic Goods Administration has commenced proceedings in the Federal Court of Australia against Philips Electronics Australia Limited (PEAL) for the alleged unlawful supply of medical devices that did not meet Australian safety and performance requirements.
-
Safety updatesNew warnings added of risks during anaesthesia or deep sedation.
-
NewsTemporary risk-based strategies are being introduced to expedite the reduction of the Good Manufacturing Practice (GMP) Clearance Compliance Verification (CV) backlog.
-
NewsFollowing a public consultation process , the TGA has adopted the following 19 international scientific guidelines.
-
Safety updatesInformation for health professionals about medicines with safety related updates to their Product Information.
-
NewsOur Good Manufacturing Practice (GMP) Clearance information resources have been updated with new information for Sponsors
-
BlogA simple post from a respected person can influence the purchasing decisions of many people. If your post meets this definition of advertising, make sure you are complying with the law. Here are some of the important rules to keep in mind when creating content.
-
BlogIn many cases, pharmacists and prescribers are able to provide or prescribe another approved medicine that is on the Australian Register of Therapeutic Goods (ARTG) or they can give a different strength or dosage of the same medicine.
-
Safety updatesRisk of Guillain-Barre syndrome added to Product Information.
-
Safety updatesUpdated illustrations clarify how to use measuring syringe for oral solutions.
-
BlogLike all goods available in Australia, therapeutic goods can sometimes experience problems. When this happens, we decide if a ‘market action’ is needed. A market action aims to correct the problem. There are four types of market actions you should be aware of.
-
BlogComplementary medicines are therapeutic goods that are often derived from traditional medicine practices. They can usually be purchased from supermarkets, health stores and pharmacies without seeing a doctor or pharmacist.
However, just because a medicine is available without a prescription, or claims to be ‘natural’ or ‘healthy’, doesn’t mean it’s safe for you. -
BlogWhile we encourage health practitioners to prescribe approved therapeutic goods where possible, unapproved therapeutic goods can be accessed in limited circumstances.
In making these joint decisions to use an unapproved therapeutic good, your doctor is required to inform you of the potential benefits and risks. -
Safety updatesInformation for health professionals about medicines with safety related updates to their Product Information.
-
NewsUpdated information for nitrosamine impurities in medicines consistent with recent EMA updated information.
-
NewsThe dual labelling period for some medicine ingredients is ending on 30 April 2025.
-
NewsWe are seeking applications from professionals with relevant expertise in medicine and science, and consumers with relevant expertise in consumer perspectives and issues.
-
Media releasesWe have issued 4 infringement notices totalling $75,120 to Queensland based pharmacy Summit Pharmacy Pty Ltd, for the alleged unlawful manufacturing of medicinal cannabis products.
-
NewsWe will be initiating targeted compliance reviews of selected listed medicines that are required to display a warning statement
-
Compliance undertakingsWe have accepted a court-enforceable undertaking from Your Solution Compounding Pharmacy Pty Ltd, regarding advertising of prescription-only compounded medicines for weight-loss.
-
Media releasesWe have accepted a court-enforceable undertaking from Your Solution Compounding Pharmacy Pty Ltd, regarding advertising of prescription-only compounded medicines for weight-loss.
-
Safety updatesUpdates further highlight potential risks of mood-related changes and sexual disorders.
-
NoticesUpdate on the progress in reducing the backlog of GMP Clearance Compliance Verification (CV) applications.
-
NewsThe Prescription Medicines in Pregnancy database has now been updated to include the following new entries:
Pages
- Current page 1
- Page 2
- Page 3
- Page 4
- Page 5
- Page 6
- Page 7
- Page 8
- Page 9
- …
- Next page Next ›
- Last page Last »